A novel compound eliminates disease-causing segments of RNA associated with ALS and dementia, and restores the health of neurons in mouse models.
Proteins associated with motor neuron disease, or ALS are present in the gut many years before disease pathologies can be found in the brain. A stool sample or gut biopsy could help identify the presence of MND-associated proteins years before symptoms appear.
With the help of AI, researchers are developing digital biomarkers that use speech data to identify ALS and frontotemporal dementia.
Using MEG neuroimaging, researchers have identified a new marker that can be used to predict the clinical outcomes for those suffering from ALS.
Those working in production occupations, especially those exposed to volatile organic compounds, metals, combustion pollutants, and particulate matter have a higher risk of developing ALS.
Early-to-midlife infections that require hospital care are associated with an increased risk of developing Alzheimer's and Parkinson's disease later in life, a new study reports.
The gut microbiome has previously been linked to some neurological and psychological disorders. Now, researchers are investigating whether utilizing microbes from the gut could potentially treat those suffering from depression and other mental health disorders.
A new study reports that abnormalities in the SOD1 protein are a common factor in all types of motor neuron diseases.
Terazosin, a drug commonly prescribed for the treatment of enlarged prostate and high blood pressure, shows promise as a treatment for ALS.
